CORCEPT THERAPEUTICS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 600.00K shares, a 66.67% decline year-over-year.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 1.03M shares, a 6.18% decline year-over-year.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 900.00K shares, a 50.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 900.00K shares, a 10.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 3.54M shares, a 53.43% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 2.31M shares, a 2.08% decline from fiscal 2023.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 2.35M shares, a 36.02% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 3.68M shares, a 20.53% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 3.54M shares 10-K · filed 2026-02-24 | |
| 2024-12-31 | 2.31M shares 10-K · filed 2025-02-26 | |
| 2023-12-31 | 2.35M shares 10-K · filed 2024-02-15 | |
| 2022-12-31 | 3.68M shares 10-K · filed 2023-02-28 | |
| 2022-03-31 | 600.00K shares 10-Q · filed 2022-05-05 | 3.43M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 1.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 4.63M shares 10-K · filed 2022-02-15 |
| 2021-09-30 | 900.00K shares 10-Q · filed 2021-11-03 | 4.70M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-06-30 | 900.00K shares 10-Q · filed 2021-07-29 | 4.40M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-03-31 | 1.80M shares 10-Q · filed 2022-05-05 | 4.50M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 1.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 2.80M shares 10-K · filed 2022-02-15 |
| 2020-09-30 | 600.00K shares 10-Q · filed 2021-11-03 | 2.30M shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 1.00M shares 10-Q · filed 2021-07-29 | 2.20M shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 100.00K shares 10-Q · filed 2021-05-06 | 1.50M shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 600.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 2.90M shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 500.00K shares 10-Q · filed 2020-11-03 | 2.99M shares derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | 300.00K shares 10-Q · filed 2020-08-04 | 2.60M shares derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | 1.50M shares 10-Q · filed 2020-05-04 | 3.12M shares derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | 692.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | 2.10M shares 10-K · filed 2021-02-23 |
| 2018-09-30 | 108.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 2.04M shares derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | 821.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 2.65M shares derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | 479.00K shares 10-Q · filed 2018-05-09 | 2.08M shares derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | 635.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | 2.01M shares 10-K · filed 2020-02-24 |
| 2017-09-30 | 720.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 3.20M shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | 250.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 2.88M shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | 402.00K shares 10-Q · filed 2017-05-02 | 3.44M shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | 1.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 3.07M shares 10-K · filed 2019-02-26 |
| 2016-09-30 | 400.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | 2.18M shares derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | 810.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 2.25M shares derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | 29.00K shares 10-Q · filed 2016-05-04 | 1.95M shares derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | 941.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | 2.04M shares 10-K · filed 2018-02-28 |
| 2015-09-30 | 473.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 1.38M shares derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | 507.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 908.00K shares derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | 120.00K shares 10-Q · filed 2015-05-08 | 661.00K shares derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | 281.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | 1.38M shares 10-K · filed 2017-03-06 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2014-06-30 | 260.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | |
| 2014-03-31 | 840.00K shares 10-Q · filed 2014-05-12 | |
| 2013-12-31 | 35.00K shares 10-K · filed 2016-03-10 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | 165.00K shares 10-K · filed 2015-03-13 |
| 2012-09-30 | 30.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | |
| 2011-12-31 | 246.00K shares 10-K · filed 2014-03-14 | |
| 2010-12-31 | 124.00K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |